David A. Siegel Novo Nordisk A S Transaction History
Two Sigma Advisers, LP
- $42.8 Billion
- Q1 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Novo Nordisk A S stock. As of the latest transaction made, Two Sigma Advisers, LP holds 4,856,800 shares of NVO stock, worth $358 Million. This represents 0.79% of its overall portfolio holdings.
Number of Shares
4,856,800
Previous 1,021,700
375.36%
Holding current value
$358 Million
Previous $87.9 Million
283.74%
% of portfolio
0.79%
Previous 0.21%
Shares
30 transactions
Others Institutions Holding NVO
# of Institutions
1,769Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.39 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.09 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$914 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$909 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$876 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $167B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...